Keyphrases
Autopsy
100%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Precision Medicine
100%
Phenomics
100%
Severe Pain
27%
Precision Oncology
27%
Prostate Cancer Biomarker
18%
Prostate Cancer Outcomes
18%
Neuroendocrine Differentiation
18%
Novel Phenotypes
18%
Statistical Analysis
9%
Logistic Regression
9%
Future Information
9%
Delayed Diagnosis
9%
Analgesic
9%
Prostate Cancer
9%
Metastasis
9%
Outcome Prediction
9%
Measurement Analysis
9%
Multiple Testing
9%
Disease Burden
9%
Body Mass Index
9%
Systematic Identification
9%
Large Cohort
9%
Survival Analysis
9%
Metastatic Site
9%
Prostate-specific Antigen
9%
Total Prostate-specific Antigen
9%
Autopsy Study
9%
Prostate-specific Antigen Level
9%
Bone Fracture
9%
Time Since Death
9%
First Occurrence
9%
Low-grade Tumor
9%
Data Requirements
9%
Probability of Death
9%
Early Death
9%
Pleural Effusion
9%
Biomarker Studies
9%
Feature Exploration
9%
Neuroendocrine Markers
9%
Spinal Cord Compression
9%
Cachexia
9%
Draft Recommendation
9%
Rapid Autopsy
9%
Gleason Grade Group 5
9%
Testing Analysis
9%
Subdural
9%
Oncology Trials
9%
Severe Anemia
9%
Data Identification
9%
Last Year of Life
9%
Skeletal-related Events
9%
Medicine and Dentistry
Prostate Cancer
100%
Personalized Medicine
100%
Phenomics
100%
Oncology
30%
Biological Marker
20%
Prostate Specific Antigen
20%
Cancer Biomarkers
20%
Neuroendocrine Differentiation
20%
Neoplasm
10%
Logistic Regression Analysis
10%
Disease Burden
10%
Body Mass Index
10%
Cancer
10%
Metastatic Carcinoma
10%
Survival Analysis
10%
Gleason Score
10%
Outcome Assessment
10%
Fracture
10%
Pleura Effusion
10%
Anemia
10%
Prognosis
10%
Spinal Cord Compression
10%
Biomarker Study
10%
Cachexia
10%
Biochemistry, Genetics and Molecular Biology
Prostate-Specific Antigen
100%
Classification
50%
Body Mass
50%
Gleason Score
50%
Disease Burden
50%
Biomarker Study
50%
Neuroscience
Prostate
100%
Prostate Specific Antigen
22%
Behavior (Neuroscience)
11%
Body Mass Index
11%
Spinal Cord Compression
11%
Survival Analysis
11%
Cachexia
11%